BACKGROUND
• Psychosis risk syndrome (PRS) is conceptualized as a transitional clinical stage between reasonably "stable" premorbid functioning and the onset of a diagnosable psychotic illness 1, 2 .
• Cognitive dysfunction is a hallmark feature of schizophrenia 3 with deficits found even in the nascent phases of psychosis 4, 5 .
• PRS studies shed light on the nature and progression of neurocognitive functioning in the period between the premorbid phase and first episode schizophrenia.
• Our primary goals were to:
1) Determine the magnitude of PRS-control differences in neurocognitive functioning.
2) Provide a quantitative benchmark for cross-sectional comparisons with meta-analytic findings from pre-and postmorbid samples.
3) Compare PRS individuals who transitioned to psychosis with those who did not in order to provide data on potential neurocognitive predictors of psychosis.
4) Determine the influence of moderator variables (e.g., sample characteristics including ascertainment methods and clinical features) on effect sizes. 
RESULTS

DISCUSSION
• Mild cognitive deficits are reliably and broadly present in PRS samples, falling at a level intermediate between those of healthy and schizophrenia samples, and comparable to those at familial ("genetic") risk and the premorbid levels of later schizophrenia samples.
• Baseline neurocognition in PRS individuals who converted to psychosis showed more severe deficits than non-converters in nearly all domains.
• Cognitive impairments tended to be greater in PRS samples with a higher percentage of individuals at familial risk for psychosis.
• Considerable heterogeneity of ESs across studies in many domains underscores variability in phenotypic expression and/or measurement sensitivity, and a critical need for improved reporting of sample characteristics to support moderator variable analyses.
• Though the findings suggest that cognitive impairment likely increases from some point in the prodromal period until the first episode of schizophrenia, there remains a need for well-designed and sufficiently powered longitudinal studies to determine the course(s) of cognitive deficits in schizophrenia.
• For PRS individuals with emerging cognitive deficits, tailored and targeted interventions such as cognitive remediation may be particularly effective in improving psychosocial outcomes. 
METHODS
• Studies were identified through computerized searches of MEDLINE (PubMed) and PsycINFO bibliographic databases between mid-2009 and early 2011 (including in-press articles).
• Inclusion criteria included studies that a) were written in English, b) provided baseline or study-entry neuropsychological data for a clearly defined PRS sample, c) included a healthy comparison group, and d) reported study statistics convertible to effect sizes (ES).
• Exclusion criteria included: a) studies based on comparisons with psychiatric, first-episode or help-seeking groups, or test norms alone or b) studies of schizotypal personality disorder only or those using "psychosis proneness" scales.
• We treated separately published studies of the same participant sample as a single study with multiple independent variables.
• The literature search yielded 14 publications (based on 8 separate samples) between 2002 and 2010, yielding a total of 1215 persons with PRS and 851 control subjects.
• ES are the standardized mean differences (SMD) between PRS and control group scores or Cohen's d (Cohen, 1988 ).
• Ten of the 14 studies (71.4%) reported matching PRS and control samples; the most frequent matching variables included age (64.3%) and sex (50%).
• Neurocognitive tests were categorized into 10 domains (3 attention sub-domains). 
